C−Boron Enolates Enable Palladium Catalyzed Carboboration of Internal 1,3‐Enynes
作者:Ziyong Wang、Jason Wu、Walid Lamine、Bo Li、Jean‐Marc Sotiropoulos、Anna Chrostowska、Karinne Miqueu、Shih‐Yuan Liu
DOI:10.1002/anie.202108534
日期:2021.9.20
generated by a kinetically controlled halogenexchange between chlorocatecholborane and silylketene acetals, is described. These C−boron enolates are demonstrated to activate 1,3-enyne substrates in the presence of a Pd0/Senphos ligand complex, resulting in the first examples of a carboboration reaction of an alkyne with enolate-equivalent nucleophiles. Highly substituted dienyl boron building blocks are
MPAI-Ligand Accelerated Pd-Catalyzed C(<i>sp</i><sup>3</sup>)–H Arylation of Free Aliphatic Acids
作者:Zi-Yu Dong、Jia-Hui Zhao、Peng Wang、Jin-Quan Yu
DOI:10.1021/acs.orglett.2c02933
日期:2022.10.28
PROCESS FOR PREPARATION OF NITROGEN MUSTARD DERIVATIVES
申请人:Oncopeptides AB
公开号:EP3280721B1
公开(公告)日:2020-07-22
Compositions and Methods For Modulating Dopamine Nerutransmission
申请人:Liu Fang
公开号:US20080213271A1
公开(公告)日:2008-09-04
The present invention provides for diagnosis or treatment of neurological or neuropsyciatric disorders involving abnormal dopamine neurotransmission. Methods and agents are provided for modulating dopamine transporter activity and modulating dopaminergic neurotransmission. Agents of the present invention include fragments of D2 receptor or dopamine transporter (DAT) that can disrupt D2-DAT coupling.
COMPOSITIONS AND METHODS FOR MODULATING DOPAMINE NEUROTRANSMISSION
申请人:LIU FANG
公开号:US20110091467A1
公开(公告)日:2011-04-21
The present invention provides for diagnosis or treatment of neurological or neuropsychiatric disorders involving abnormal dopamine neurotransmission. Methods and agents are provided for modulating dopamine transporter activity and modulating dopaminergic neurotransmission. Agents of the present invention include fragments of D2 receptor or dopamine transporter (DAT) that can disrupt D2-DAT coupling.